Pseudomonas aeruginosa infections of the eye

California Medicine
|December 1, 1953
PubMed

Insights

Polymyxin B effectively treated Pseudomonas aeruginosa eye infections in rabbits, preventing or localizing corneal ulcers. Early treatment showed the best results, with hyaluronidase having no added benefit.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa typically causes chronic infections with minimal systemic response.
  • Ocular P. aeruginosa infections, often from trauma or contaminated substances, exhibit extreme virulence, leading to blindness.
  • Previous antibiotic treatments for P. aeruginosa have shown limited success.

Purpose of the Study:

  • To evaluate the efficacy of polymyxin B in treating experimental Pseudomonas aeruginosa keratitis in rabbits.
  • To determine the impact of treatment timing on the effectiveness of polymyxin B.

Main Methods:

  • Experimental Pseudomonas aeruginosa keratitis was induced in 18 rabbits.
  • Treated eyes received subconjunctival polymyxin B injections with epinephrine every 48 hours; control eyes were untreated.
  • Treatment was initiated immediately, 24 hours, or 48 hours post-inoculation.

Main Results:

  • Immediate polymyxin B treatment prevented corneal ulcers in 5 out of 6 rabbits.
  • Delayed treatment (24 or 48 hours) localized ulcer progression compared to controls.
  • Addition of hyaluronidase to polymyxin B showed no discernible benefit.

Conclusions:

  • Polymyxin B demonstrates significant efficacy in managing Pseudomonas aeruginosa keratitis in rabbits.
  • Timely administration of polymyxin B is crucial for optimal outcomes in P. aeruginosa ocular infections.
  • Further research may explore optimized polymyxin B formulations for ocular infections.

Related Concept Videos

Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...